Daytime drowsiness occurs if the PM capsule is taken very late at night without adequate sleep hours
Having a medication approved for OSA opens a whole new avenue for treatment. The approval followed the success of the SURMOUNT-OSA trial, a pivotal study designed to evaluate the impact of tirzepatide on sleep apnea
Adams, J., Lauterburg, B
However, Inzucchi suggested that younger patients and those without hypertension may benefit from semaglutide for stroke prevention
Pancreas, Gallbladder, Kidney, and Gastrointestinal Safety Questions Approved GLP-1 and GLP-1/GIP therapies include warnings or precautions related to issues such as pancreatitis, gallbladder disease, acute kidney injury, severe gastrointestinal reactions, and hypersensitivity, depending on product labeling [12], [13]